These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32636771)

  • 1. Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
    Cheng Z; Yuan Y; Han X; Yang L; Zeng X; Yang F; Lu Z; Wang C; Deng H; Zhao J; Yu X
    Front Psychiatry; 2020; 11():566. PubMed ID: 32636771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients.
    Nakajima S; Higuchi Y; Tateno T; Sasabayashi D; Mizukami Y; Nishiyama S; Takahashi T; Suzuki M
    Front Psychiatry; 2021; 12():777378. PubMed ID: 34899430
    [No Abstract]   [Full Text] [Related]  

  • 3. One-year follow-up of patients with first-episode schizophrenia (comparison between remitters and non-remitters).
    Cesková E; Radovan P; Tomás K; Hana K
    Neuropsychiatr Dis Treat; 2007 Feb; 3(1):153-60. PubMed ID: 19300545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia.
    Jelastopulu E; Giourou E; Merekoulias G; Mestousi A; Moratis E; Alexopoulos EC
    BMC Psychiatry; 2014 Jul; 14():197. PubMed ID: 25005616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year Outcome of First vs. Later Episode Schizophrenia: A Real-world Naturalistic Study.
    Fountoulakis KN; Panagiotidis P; Theofilidis AT; Nimatoudis I
    Clin Psychopharmacol Neurosci; 2020 Aug; 18(3):434-444. PubMed ID: 32702222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses.
    Haddad PM; Correll CU
    Ther Adv Psychopharmacol; 2018 Nov; 8(11):303-318. PubMed ID: 30344997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.
    Li X; Guo X; Fan X; Feng T; Wang C; Yao Z; Xu X; Chen Z; Wang H; Xie S; He J; Zhuo K; Xiang Q; Cen H; Wang J; Smith RC; Jin H; Keshavan MS; Marder SR; Davis JM; Jiang K; Xu Y; Liu D
    Schizophr Res; 2021 Apr; 230():87-94. PubMed ID: 33279374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
    J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of time and duration of untreated psychosis on cognitive and social functioning in Chinese patients with first-episode schizophrenia: A 1-year study.
    Heeramun-Aubeeluck A; Liu N; Fischer F; Huang N; Chen F; He L; Yang C; Luo Y; Lu Z
    Nord J Psychiatry; 2015 May; 69(4):254-61. PubMed ID: 25731069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study.
    Chen YQ; Li XR; Zhang L; Zhu WB; Wu YQ; Guan XN; Xiu MH; Zhang XY
    J Clin Psychiatry; 2021 May; 82(3):. PubMed ID: 34004092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes.
    Cheng Z; Yuan Y; Han X; Yang L; Cai S; Yang F; Lu Z; Wang C; Deng H; Zhao J; Xiang Y; Correll CU; Yu X
    J Psychopharmacol; 2019 Oct; 33(10):1227-1236. PubMed ID: 31487208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between clinical outcomes measures and personal and social performance functioning in a prospective, interventional study in schizophrenia.
    Vauth R; Carpiniello B; Turczyński J; Ivanov M; Cherubin P; Lahaye M; Schreiner A
    Int J Methods Psychiatr Res; 2021 Jun; 30(2):e1855. PubMed ID: 33355966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosis.
    Si T; Tan Q; Zhang K; Wang Y; Rui Q
    Neuropsychiatr Dis Treat; 2015; 11():87-95. PubMed ID: 25657581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents.
    Kim EY; Chang SM; Shim JC; Joo EJ; Kim JJ; Kim YS; Ahn YM
    Curr Med Res Opin; 2013 Oct; 29(10):1231-40. PubMed ID: 23777311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study.
    Kane JM; Peters-Strickland T; Baker RA; Hertel P; Eramo A; Jin N; Perry PP; Gara M; McQuade RD; Carson WH; Sanchez R
    J Clin Psychiatry; 2014 Nov; 75(11):1254-60. PubMed ID: 25188501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cross-Sectional Study on Associations Between BDNF, CRP, IL-6 and Clinical Symptoms, Cognitive and Personal Performance in Patients With Paranoid Schizophrenia.
    Chumakov E; Dorofeikova M; Tsyrenova K; Petrova N
    Front Psychiatry; 2022; 13():943869. PubMed ID: 35873262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics.
    Yin P; Zhao C; Li Y; Liu X; Chen L; Hong N
    Front Psychiatry; 2021; 12():735623. PubMed ID: 34916969
    [No Abstract]   [Full Text] [Related]  

  • 20. Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia.
    Ohnishi T; Wakamatsu A; Kobayashi H
    Neuropsychiatr Dis Treat; 2021; 17():1095-1104. PubMed ID: 33888985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.